{"pmid":32188484,"title":"Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan.","text":["Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan.","Crit Care","Shi, Yu","Yu, Xia","Zhao, Hong","Wang, Hao","Zhao, Ruihong","Sheng, Jifang","32188484"],"journal":"Crit Care","authors":["Shi, Yu","Yu, Xia","Zhao, Hong","Wang, Hao","Zhao, Ruihong","Sheng, Jifang"],"date":"2020-03-20T11:00:00Z","year":2020,"_id":"32188484","week":"202012|Mar 16 - Mar 22","doi":"10.1186/s13054-020-2833-7","keywords":["COVID-2019","Disease severity","Host susceptibility","Risk factors"],"source":"PubMed","locations":["Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Diagnosis"],"weight":1,"_version_":1661729351551418368,"score":6.823649,"similar":[{"pmid":32187887,"title":"Insight into COVID-2019 for pediatricians.","text":["Insight into COVID-2019 for pediatricians.","Since December 2019, patients with unexplained pneumonia have been found in Wuhan City, Hubei Province, China. The pathogen in these cases is a new type of coronavirus. The World Health Organization confirmed this diagnosis and named the pathogen SARSCoV-2. The disease caused by SARSCoV-2 is called Corona Virus Disease (COVID-2019). The virus is highly infectious and pathogenic, causing human-to-human transmission. At present, SARSCoV-2 is still rampant in the world. Zhengzhou City in Henan Province serves as an example, 102 people have been confirmed to be infected with SARSCoV-2 (at 24:00 on February 5th, 2020), including three children, the youngest is 4 years old. From the perspective of clinical pediatricians as the first line fighting the epidemic, this paper will discuss the clinical characteristics, prevention and control measures, outcomes, diagnosis, and treatment of pediatric cases.","Pediatr Pulmonol","Li, Yuanzhe","Guo, FeiFei","Cao, Yang","Li, LiFeng","Guo, YanJun","32187887"],"abstract":["Since December 2019, patients with unexplained pneumonia have been found in Wuhan City, Hubei Province, China. The pathogen in these cases is a new type of coronavirus. The World Health Organization confirmed this diagnosis and named the pathogen SARSCoV-2. The disease caused by SARSCoV-2 is called Corona Virus Disease (COVID-2019). The virus is highly infectious and pathogenic, causing human-to-human transmission. At present, SARSCoV-2 is still rampant in the world. Zhengzhou City in Henan Province serves as an example, 102 people have been confirmed to be infected with SARSCoV-2 (at 24:00 on February 5th, 2020), including three children, the youngest is 4 years old. From the perspective of clinical pediatricians as the first line fighting the epidemic, this paper will discuss the clinical characteristics, prevention and control measures, outcomes, diagnosis, and treatment of pediatric cases."],"journal":"Pediatr Pulmonol","authors":["Li, Yuanzhe","Guo, FeiFei","Cao, Yang","Li, LiFeng","Guo, YanJun"],"date":"2020-03-19T11:00:00Z","year":2020,"_id":"32187887","week":"202012|Mar 16 - Mar 22","doi":"10.1002/ppul.24734","keywords":["COVID-2019","SARSCoV-2","pediatric infection"],"source":"PubMed","locations":["Wuhan","China","Zhengzhou","Henan","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Diagnosis","Treatment"],"weight":1,"_version_":1661633092436099072,"score":65.32276},{"pmid":32100877,"title":"Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2.","text":["Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2.","From the beginning of 2002 and 2012, severe respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) crossed the species barriers to infect humans, causing thousands of infections and hundreds of deaths, respectively. Currently, a novel coronavirus (SARS-CoV-2), which has become the cause of the outbreak of Coronavirus Disease 2019 (COVID-19), was discovered. Until 18 February 2020, there were 72 533 confirmed COVID-19 cases (including 10 644 severe cases) and 1872 deaths in China. SARS-CoV-2 is spreading among the public and causing substantial burden due to its human-to-human transmission. However, the intermediate host of SARS-CoV-2 is still unclear. Finding the possible intermediate host of SARS-CoV-2 is imperative to prevent further spread of the epidemic. In this study, we used systematic comparison and analysis to predict the interaction between the receptor-binding domain (RBD) of coronavirus spike protein and the host receptor, angiotensin-converting enzyme 2 (ACE2). The interaction between the key amino acids of S protein RBD and ACE2 indicated that, other than pangolins and snakes, as previously suggested, turtles (Chrysemys picta bellii, Chelonia mydas, and Pelodiscus sinensis) may act as the potential intermediate hosts transmitting SARS-CoV-2 to humans.","J Med Virol","Liu, Zhixin","Xiao, Xiao","Wei, Xiuli","Li, Jian","Yang, Jing","Tan, Huabing","Zhu, Jianyong","Zhang, Qiwei","Wu, Jianguo","Liu, Long","32100877"],"abstract":["From the beginning of 2002 and 2012, severe respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) crossed the species barriers to infect humans, causing thousands of infections and hundreds of deaths, respectively. Currently, a novel coronavirus (SARS-CoV-2), which has become the cause of the outbreak of Coronavirus Disease 2019 (COVID-19), was discovered. Until 18 February 2020, there were 72 533 confirmed COVID-19 cases (including 10 644 severe cases) and 1872 deaths in China. SARS-CoV-2 is spreading among the public and causing substantial burden due to its human-to-human transmission. However, the intermediate host of SARS-CoV-2 is still unclear. Finding the possible intermediate host of SARS-CoV-2 is imperative to prevent further spread of the epidemic. In this study, we used systematic comparison and analysis to predict the interaction between the receptor-binding domain (RBD) of coronavirus spike protein and the host receptor, angiotensin-converting enzyme 2 (ACE2). The interaction between the key amino acids of S protein RBD and ACE2 indicated that, other than pangolins and snakes, as previously suggested, turtles (Chrysemys picta bellii, Chelonia mydas, and Pelodiscus sinensis) may act as the potential intermediate hosts transmitting SARS-CoV-2 to humans."],"journal":"J Med Virol","authors":["Liu, Zhixin","Xiao, Xiao","Wei, Xiuli","Li, Jian","Yang, Jing","Tan, Huabing","Zhu, Jianyong","Zhang, Qiwei","Wu, Jianguo","Liu, Long"],"date":"2020-02-27T11:00:00Z","year":2020,"_id":"32100877","week":"20209|Feb 24 - Mar 01","doi":"10.1002/jmv.25726","keywords":["Coronavirus Disease 2019 (COVID-19)","SARS-CoV-2","SARS-CoV-2 spike protein (S)","angiotensin-converting enzyme 2 (ACE2)","receptor-binding domain (RBD) of coronavirus"],"source":"PubMed","locations":["Pelodiscus","Chelonia","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Transmission","Mechanism"],"weight":1,"_version_":1661359647472222208,"score":52.23212},{"pmid":32172672,"title":"A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses.","text":["A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses.","World Health Organization has declared the ongoing outbreak of coronavirus disease 2019 (COVID-19) a Public Health Emergency of International Concern. The virus was named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the International Committee on Taxonomy of Viruses. Human infection with SARS-CoV-2 leads to a wide range of clinical manifestations ranging from asymptomatic, mild, moderate to severe. The severe cases present with pneumonia, which can progress to acute respiratory distress syndrome. The outbreak provides an opportunity for real-time tracking of an animal coronavirus that has just crossed species barrier to infect humans. The outcome of SARS-CoV-2 infection is largely determined by virus-host interaction. Here, we review the discovery, zoonotic origin, animal hosts, transmissibility and pathogenicity of SARS-CoV-2 in relation to its interplay with host antiviral defense. A comparison with SARS-CoV, Middle East respiratory syndrome coronavirus, community-acquired human coronaviruses and other pathogenic viruses including human immunodeficiency viruses is made. We summarize current understanding of the induction of a proinflammatory cytokine storm by other highly pathogenic human coronaviruses, their adaptation to humans and their usurpation of the cell death programmes. Important questions concerning the interaction between SARS-CoV-2 and host antiviral defence, including asymptomatic and presymptomatic virus shedding, are also discussed.","Emerg Microbes Infect","Fung, Sin-Yee","Yuen, Kit-San","Ye, Zi-Wei","Chan, Chi-Ping","Jin, Dong-Yan","32172672"],"abstract":["World Health Organization has declared the ongoing outbreak of coronavirus disease 2019 (COVID-19) a Public Health Emergency of International Concern. The virus was named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the International Committee on Taxonomy of Viruses. Human infection with SARS-CoV-2 leads to a wide range of clinical manifestations ranging from asymptomatic, mild, moderate to severe. The severe cases present with pneumonia, which can progress to acute respiratory distress syndrome. The outbreak provides an opportunity for real-time tracking of an animal coronavirus that has just crossed species barrier to infect humans. The outcome of SARS-CoV-2 infection is largely determined by virus-host interaction. Here, we review the discovery, zoonotic origin, animal hosts, transmissibility and pathogenicity of SARS-CoV-2 in relation to its interplay with host antiviral defense. A comparison with SARS-CoV, Middle East respiratory syndrome coronavirus, community-acquired human coronaviruses and other pathogenic viruses including human immunodeficiency viruses is made. We summarize current understanding of the induction of a proinflammatory cytokine storm by other highly pathogenic human coronaviruses, their adaptation to humans and their usurpation of the cell death programmes. Important questions concerning the interaction between SARS-CoV-2 and host antiviral defence, including asymptomatic and presymptomatic virus shedding, are also discussed."],"journal":"Emerg Microbes Infect","authors":["Fung, Sin-Yee","Yuen, Kit-San","Ye, Zi-Wei","Chan, Chi-Ping","Jin, Dong-Yan"],"date":"2020-03-17T11:00:00Z","year":2020,"_id":"32172672","week":"202012|Mar 16 - Mar 22","doi":"10.1080/22221751.2020.1736644","keywords":["2019 novel coronavirus","COVID-19","Coronavirus","SARS-CoV","SARS-CoV-2","host antiviral response","type I interferon"],"source":"PubMed","topics":["Mechanism","Transmission"],"weight":1,"_version_":1661456248821776385,"score":47.324867},{"pmid":32147409,"title":"Are children less susceptible to COVID-19?","text":["Are children less susceptible to COVID-19?","J Microbiol Immunol Infect","Lee, Ping-Ing","Hu, Ya-Li","Chen, Po-Yen","Huang, Yhu-Chering","Hsueh, Po-Ren","32147409"],"journal":"J Microbiol Immunol Infect","authors":["Lee, Ping-Ing","Hu, Ya-Li","Chen, Po-Yen","Huang, Yhu-Chering","Hsueh, Po-Ren"],"date":"2020-03-10T11:00:00Z","year":2020,"_id":"32147409","week":"202011|Mar 09 - Mar 15","doi":"10.1016/j.jmii.2020.02.011","source":"PubMed","topics":["Mechanism"],"weight":1,"_version_":1661359647818252288,"score":47.15426},{"pmid":32130973,"title":"A potential role for integrins in host cell entry by SARS-CoV-2.","text":["A potential role for integrins in host cell entry by SARS-CoV-2.","Antiviral Res","Sigrist, Christian Ja","Bridge, Alan","Le Mercier, Philippe","32130973"],"journal":"Antiviral Res","authors":["Sigrist, Christian Ja","Bridge, Alan","Le Mercier, Philippe"],"date":"2020-03-05T11:00:00Z","year":2020,"_id":"32130973","week":"202010|Mar 02 - Mar 08","doi":"10.1016/j.antiviral.2020.104759","source":"PubMed","topics":["Mechanism"],"weight":1,"_version_":1661359647674597376,"score":47.146835}]}